医药国企改革重点标的一览 基金重仓四股(2)

www.yingfu001.com 2015-10-23 17:23 赢富财经网我要评论

  国药股份:经营性现金流同比大幅增加,业务运营十分健康

  国药股份 600511

  研究机构:申万宏源 分析师:罗佳荣 撰写日期:2015-10-21

  投资要点:

  2015年前三季度收入增长6.2%,扣非净利润增长4.4%。2015年前三季度公司累计实现收入90.7亿,增长6.2%,归母净利润3.9亿,增长4.4%,扣非后净利润3.8亿,增长4.4%,EPS0.80元,略低于我们三季报前瞻中预期。其中:三季度单季实现收入31.3亿,增长5.8%,净利润1.4亿,增长2.5%,扣非后净利润1.3亿,与去年同期持平,EPS0.27元。

  麻药分销收入预计增长约20%,宜昌人福三季度单季投资收益增长约20%。分业务来看,预计麻药分销收入增长约20%,医药纯销受北京医院减少备货影响,小幅负增长,商业调拨收入平稳增长,麻药收入占比提升而纯销收入占比下降是主业毛利率小幅下降的核心原因。我们预计三季度单季参宜昌人福贡献投资收益同比增长约20%,青海制药贡献权益负增长。

  期间费用率小幅下降,经营效率稳步提升。期间费用率3.4%,同比下降0.1个百分点,其中销售费用率1.9%,与去年同期持平,管理费用率1.4%,同比增加0.1个百分点,财务费用率0.1%,同比下降0.2个百分点。每股经营性现金流0.80元,增长30.0%,表明公司经营十分健康。

  未来稳定增长可期,维持买入评级。麻药平台定位清晰,预计未来将通过参股更多麻药工业,整合麻药二级分销商,全面试点麻药电子印签卡,加强麻药产业链控制力;创新医药增值服务,托管药房,扩大医药纯销份额;与辉瑞合作成立全国零售分销平台,国药商城正式上线,创新业务模式。我们小幅下调公司15-17年盈利预测至EPS1.06元、1.26元、1.52元(1.21元、1.49元、1.82元),同比增长6%、18%、21%,对应预测市盈率32倍、27倍、22倍,国药控股承诺5年内解决关联交易问题,2016年5月承诺即将到期,公司经营依然十分健康,未来稳定增长可期,维持买入评级。

基金名称持股数(万股)持股比例持仓变化(万股)持股市值(万元)占净值比例占个股流通市值比例
34.680.3634.681747.770.280.12
10.002.4410.00503.901.680.04
106.234.39106.235352.913.050.38
23.001.2723.001158.970.890.08
18.570.8418.57935.740.720.07
4.980.514.98251.070.470.02
150.003.27-230.007558.502.660.54
400.004.18400.0020156.003.271.44
1.160.031.1658.450.030.00
2.503.972.50125.982.360.01
100.002.23100.005039.001.660.36
795.1016.87-200.9040065.2110.282.86
300.005.52300.0015117.114.361.08
13.305.5913.30670.194.690.05
185.325.21185.329338.033.810.67
3.705.353.70186.434.480.01
45.103.9945.102272.343.370.16
260.014.36260.0113101.794.100.94
381.483.26381.4819222.992.891.37
136.457.46136.456875.936.060.49
549.994.02549.9927714.183.351.98
597.584.40597.5830112.063.462.15
18.007.0518.00907.023.270.06
20.003.2520.001007.800.790.07
181.145.6674.169127.584.270.65
929.061.04929.0646815.520.843.35
1.456.961.4573.070.430.01
2.1829.602.18109.850.650.01
0.360.270.3618.190.260.00
0.440.240.4422.020.230.00
2.001.592.00100.781.480.01
0.180.220.189.070.170.00
5.830.385.83293.770.290.02
2.522.962.52126.981.050.01
60.514.2360.513049.103.010.22
0.800.550.8040.310.470.00
0.030.270.031.530.060.00
0.030.510.031.750.470.00
0.330.160.3316.610.130.00
100.002.32-250.005039.001.950.36
1.720.211.7286.630.200.01
9.210.379.21463.860.290.03
34.990.6534.991763.300.560.13
66.001.4766.003325.741.260.24
0.700.370.7035.270.290.00
350.008.23-140.0517636.505.721.26
0.150.700.157.780.600.00
5.004.685.00251.954.460.02
6.003.146.00302.340.060.02
41.790.7941.792105.900.420.15
232.287.24232.2811704.594.130.84
0.000.000.000.050.000.00
234.4310.72234.4311812.929.030.84
200.002.04200.0010077.891.860.72
2.470.842.47124.460.560.01
0.020.000.021.010.000.00
120.078.74120.076050.397.510.43
4.160.934.16209.620.830.02
1.002.351.0050.390.020.00
240.009.86-45.6212093.605.710.86
0.620.370.6231.120.310.00
5.919.985.91297.801.050.02
189.059.31189.059526.234.460.68
280.0010.14-50.0014109.205.931.01
8.011.328.01403.691.070.03
10.591.2710.59533.761.130.04
9.751.24-9.74491.351.170.04
0.010.000.010.500.000.00
14.490.3714.49730.320.280.05
4.002.544.00201.561.650.01
0.010.000.010.410.000.00
4.990.054.99251.590.040.02
249.912.71249.9112592.901.830.90
17.512.8217.51882.402.620.06
0.010.000.010.380.000.00
40.940.6340.942062.750.480.15
64.052.4964.053227.481.340.23
0.950.240.9547.870.170.00
2.230.112.23112.510.100.01
0.330.360.3316.560.290.00
0.100.310.105.040.010.00
6.110.386.11308.080.300.02
0.671.630.6733.761.450.00
0.010.000.010.320.000.00
1.320.431.3266.380.420.00
0.030.010.031.520.010.00
2.250.862.25113.380.560.01
34.991.9734.991763.301.690.13
11.800.2711.80594.700.240.04
0.610.370.6130.540.280.00
62.931.6062.933171.201.480.23
3.000.983.00151.170.070.01
0.190.250.199.400.230.00
40.003.0540.002015.602.240.14
56.711.2556.712857.720.820.20
37.230.6937.231876.020.520.13

相关新闻
  • 征稿启事 | 合作伙伴 | 友情链接 | 联系我们 | 广告服务 | 关于我们 | 法律声明 | 网址导航 | 虞凌云
  • 赢富财经网:www.yingfu001.com 简易域名:简易域名 版权所有 翻版必究!Copyright©2008-2022 沪ICP备10023616号-1
  • 赢富财经网所载文章、数据仅供参考,使用前务请仔细阅读免责声明,风险自负。广告商的言论和行为与赢富财经网无关,投资有风险,选择需谨慎。
  • 特别提示:赢富财经网不作任何“加入会员、承诺收益、利润分成”以及其他非法操作方式进行非法的理财服务。
  • 您有任何建议或意见,欢迎随时与我们联系!联系我们
  • 上海网警网络110工商备案360安全检测